The charts on this page feature a breakdown of the total annual pay for the top executives at KERYX BIOPHARMACEUTICALS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. KERYX BIOPHARMACEUTICALS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. KERYX BIOPHARMACEUTICALS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Gregory P. Madison
Former Chief Executive Officer and President
Total Cash $873,780 Equity $2,017,320 Other $7,604 Total Compensation $2,898,704
Brian Adams
Former General Counsel and Secretary
Total Cash $506,718 Equity $655,630 Other $5,672 Total Compensation $1,168,020
John F. Neylan
Chief Medical Officer
Total Cash $589,304 Equity $655,630 Other $6,192 Total Compensation $1,251,126
Scott A. Holmes
Chief Financial Officer and Treasurer
Total Cash $516,659 Equity $655,630 Other $3,824 Total Compensation $1,176,113
Christine Carberry
Chief Operating Officer
Total Cash $518,648 Equity $1,241,442 Other $8,019 Total Compensation $1,768,109
For its 2017 fiscal year, KERYX BIOPHARMACEUTICALS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Gregory P. Madison CEO Pay $2,898,704 Median Employee Pay $188,867 CEO Pay Ratio 15:1
For its 2017 fiscal year, KERYX BIOPHARMACEUTICALS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Daniel P. Regan Total Cash $278,794
Jodie P. Morrison Total Cash $266,318
John P. Butler Total Cash $251,040
Kevin J. Cameron Total Cash $286,336
Mark J. Enyedy Total Cash $288,287
Michael Rogers Total Cash $298,107
Michael T. Heffernan Total Cash $266,294
Steven C. Gilman Total Cash $278,885

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.